Filing Details

Accession Number:
0001570562-24-000084
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-14 20:55:50
Reporting Period:
2024-05-10
Accepted Time:
2024-05-14 20:55:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1570562 Evolus Inc. EOLS Pharmaceutical Preparations (2834) 461385614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1944884 Sandra Beaver 520 Newport Center Drive
Suite 1200
Newport Beach CA 92660
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-05-10 2,423 $12.72 151,778 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  2. The shares were sold in multiple trades at prices ranging from $12.51 to $13.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.